These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32354780)

  • 1. Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep-wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study.
    Hollinger A; von Felten S; Sutter R; Huber J; Tran F; Reinhold S; Abdelhamid S; Todorov A; Gebhard CE; Cajochen C; Steiner LA; Siegemund M
    BMJ Open; 2020 Apr; 10(4):e034873. PubMed ID: 32354780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of propofol and dexmedetomidine infused overnight to treat hyperactive and mixed ICU delirium: a protocol for the Basel ProDex clinical trial.
    Hollinger A; Ledergerber K; von Felten S; Sutter R; Rüegg S; Gantner L; Zimmermann S; Blum A; Steiner LA; Marsch S; Siegemund M
    BMJ Open; 2017 Jul; 7(7):e015783. PubMed ID: 28710219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
    Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
    Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the haemostatic effect of platelets in the presence of high normal concentrations of von Willebrand factor for critically ill patients needing platelet transfusion-a protocol for the will-plate randomised controlled trial.
    Herrmann G; Blum A; Bolliger D; Achermann R; Estermann A; Gebhard CE; Henn A; Huber J; Singh J; Todorov A; Zehnder T; Zellweger N; Buser A; Tsakiris DA; Hollinger A; Siegemund M
    Trials; 2023 Jan; 24(1):47. PubMed ID: 36670471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study.
    Burry L; Scales D; Williamson D; Foster J; Mehta S; Guenette M; Fan E; Detsky M; Azad A; Bernard F; Rose L
    BMJ Open; 2017 Mar; 7(3):e015420. PubMed ID: 28363933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands.
    Smit L; Trogrlić Z; Devlin JW; Osse RJ; Ponssen HH; Slooter AJC; Hunfeld NGM; Rietdijk WJR; Gommers D; van der Jagt M;
    BMJ Open; 2020 Sep; 10(9):e036735. PubMed ID: 32967873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial.
    Huang H; Jiang L; Shen L; Zhang G; Zhu B; Cheng J; Xi X
    Trials; 2014 Aug; 15():327. PubMed ID: 25135124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin for prevention of postoperative delirium after lower limb fracture surgery in elderly patients (DELIRLESS): study protocol for a multicentre randomised controlled trial.
    Sigaut S; Couffignal C; Esposito-Farèse M; Degos V; Molliex S; Boddaert J; Raynaud-Simon A; Durand-Zaleski I; Marcault E; Jacota M; Dahmani S; Paugam-Burtz C; Weiss E
    BMJ Open; 2021 Dec; 11(12):e053908. PubMed ID: 34952881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
    Menczel Schrire Z; Phillips CL; Duffy SL; Marshall NS; Mowszowski L; La Monica HM; Gordon CJ; Chapman JL; Saini B; Lewis SJG; Naismith SL; Grunstein RR; Hoyos CM
    BMJ Open; 2021 Feb; 11(2):e041500. PubMed ID: 33568368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial.
    de Jonghe A; van Munster BC; van Oosten HE; Goslings JC; Kloen P; van Rees C; Wolvius R; van Velde R; Levi MM; Korevaar JC; de Rooij SE;
    BMC Geriatr; 2011 Jul; 11():34. PubMed ID: 21729284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial.
    Wibrow B; Martinez FE; Myers E; Chapman A; Litton E; Ho KM; Regli A; Hawkins D; Ford A; van Haren FMP; Wyer S; McCaffrey J; Rashid A; Kelty E; Murray K; Anstey M
    Intensive Care Med; 2022 Apr; 48(4):414-425. PubMed ID: 35220473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.
    Azimaraghi O; Hammer M; Santer P; Platzbecker K; Althoff FC; Patrocinio M; Grabitz SD; Wongtangman K; Rumyantsev S; Xu X; Schaefer MS; Fuller PM; Subramaniam B; Eikermann M
    BMJ Open; 2020 Jul; 10(7):e038474. PubMed ID: 32690536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial.
    Shelton KT; Qu J; Bilotta F; Brown EN; Cudemus G; D'Alessandro DA; Deng H; DiBiasio A; Gitlin JA; Hahm EY; Hobbs LE; Houle TT; Ibala R; Loggia ML; Pavone KJ; Shaefi S; Tolis G; Westover MB; Akeju O
    BMJ Open; 2018 Apr; 8(4):e020316. PubMed ID: 29678977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical analysis plan for the Prophylactic Melatonin for Delirium in Intensive Care (ProMEDIC): a randomised controlled trial.
    Wibrow B; Martinez FE; Ford A; Kelty E; Murray K; Ho KM; Litton E; Myers E; Anstey M
    Trials; 2021 Jan; 22(1):7. PubMed ID: 33402209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.
    Bush SH; Lacaze-Masmonteil N; McNamara-Kilian MT; MacDonald AR; Tierney S; Momoli F; Agar M; Currow DC; Lawlor PG
    Trials; 2016 Aug; 17():399. PubMed ID: 27515515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
    Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H
    BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.
    Page VJ; Ely EW; Gates S; Zhao XB; Alce T; Shintani A; Jackson J; Perkins GD; McAuley DF
    Lancet Respir Med; 2013 Sep; 1(7):515-23. PubMed ID: 24461612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials.
    Zhang Q; Gao F; Zhang S; Sun W; Li Z
    Sleep Breath; 2019 Dec; 23(4):1059-1070. PubMed ID: 31119597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.
    Bourne RS; Mills GH; Minelli C
    Crit Care; 2008; 12(2):R52. PubMed ID: 18423009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled Trial.
    Gandolfi JV; Di Bernardo APA; Chanes DAV; Martin DF; Joles VB; Amendola CP; Sanches LC; Ciorlia GL; Lobo SM
    Crit Care Med; 2020 Dec; 48(12):e1286-e1293. PubMed ID: 33048904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.